Decoding viral infections and risk for asthma: Biomarkers or clinical histories?
- PMID: 38702102
- PMCID: PMC12290900
- DOI: 10.1016/j.anai.2024.02.002
Decoding viral infections and risk for asthma: Biomarkers or clinical histories?
Conflict of interest statement
Disclosures Dr Kloepfer reports payments for disease state awareness lectures for Regeneron. Dr Kennedy has no conflicts of interest to report.
Comment on
-
Azithromycin therapy in infants hospitalized for respiratory syncytial virus bronchiolitis: Airway matrix metalloproteinase-9 levels and subsequent recurrent wheeze.Ann Allergy Asthma Immunol. 2024 May;132(5):623-629. doi: 10.1016/j.anai.2024.01.001. Epub 2024 Jan 17. Ann Allergy Asthma Immunol. 2024. PMID: 38237675 Clinical Trial.
References
-
- Justice N, Le JK. Bronchiolitis. StatPearls. 2023.
-
- Bacharier LB, Cohen R, Schweiger T, Yin-Declue H, Christie C, Zheng J, Schechtman KB, Strunk RC, Castro M. Determinants of asthma after severe respiratory syncytial virus bronchiolitis. J Allergy Clin Immunol. 2012;130(1):91–100 e3. Epub 20120322. doi: 10.1016/j.jaci.2012.02.010. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
